Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? (Q38407557)

2 September 2017

Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? (English)

1 reference

2 September 2017

0 references

1 reference

cognitive dysfunction

1 reference

8

1 reference

2 September 2017

Alison J Yarnall

3

0 references

David Burn

object named as

David J Burn

7

0 references

David J. Brooks

object named as

David J Brooks

5

0 references

Roger A. Barker

6

object named as

Roger A Barker

1 reference

2 September 2017

Gordon W Duncan

1

1 reference

2 September 2017

Michael J Firbank

2

1 reference

2 September 2017

Tien K Khoo

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

22 July 2015

1 reference

2 September 2017

1 reference

2 September 2017

31

1 reference

2 September 2017

1

1 reference

2 September 2017

103-110

1 reference

Cognitive profile of patients with newly diagnosed Parkinson disease.

2 September 2017

1 reference

Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.

21 January 2018

1 reference

Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study

21 January 2018

1 reference

Evolution of mild cognitive impairment in Parkinson disease.

21 January 2018

1 reference

Cognitive status correlates with neuropathologic stage in Parkinson disease.

21 January 2018

1 reference

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

21 January 2018

1 reference

The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status.

21 January 2018

1 reference

The topography of brain damage at different stages of Parkinson's disease

21 January 2018

1 reference

Gray matter correlations of cognition in incident Parkinson's disease.

21 January 2018

1 reference

Grey matter atrophy in cognitively impaired Parkinson's disease.

21 January 2018

1 reference

Cognitive status correlates with white matter alteration in Parkinson's disease.

21 January 2018

1 reference

Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

21 January 2018

1 reference

Amygdalar and hippocampal MRI volumetric reductions in Parkinson's disease with dementia.

21 January 2018

1 reference

Cerebral atrophy and its relation to cognitive impairment in Parkinson disease.

21 January 2018

1 reference

Neurodegeneration across stages of cognitive decline in Parkinson disease

21 January 2018

1 reference

A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry

21 January 2018

1 reference

Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness.

21 January 2018

1 reference

Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy.

21 January 2018

1 reference

Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease

21 January 2018

1 reference

Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease

21 January 2018

1 reference

Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data

21 January 2018

1 reference

White matter microstructure deteriorates across cognitive stages in Parkinson disease

21 January 2018

1 reference

Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease

21 January 2018

1 reference

The incidence of Parkinson's disease in the North-East of England

21 January 2018

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan

21 January 2018

1 reference

Development and validation of a geriatric depression screening scale: a preliminary report

21 January 2018

1 reference

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

21 January 2018

1 reference

21 January 2018

1 reference

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

21 January 2018

1 reference

Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system

21 January 2018

1 reference

Voxel-based morphometry–the methods

21 January 2018

1 reference

A fast diffeomorphic image registration algorithm

21 January 2018

1 reference

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

21 January 2018

1 reference

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.

21 January 2018

1 reference

Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.

21 January 2018

1 reference

Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference.

21 January 2018

1 reference

Synaptic dysfunction in Parkinson's disease.

21 January 2018

1 reference

Stages in the development of Parkinson's disease-related pathology

21 January 2018

1 reference

Structural brain correlates of verbal fluency in Parkinson's disease.

21 January 2018

1 reference

Verbal fluency deficits in Parkinson's disease: a meta-analysis

21 January 2018

1 reference

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

21 January 2018

1 reference

The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort.

21 January 2018

1 reference

Spatial and orientational heterogeneity in the statistical sensitivity of skeleton-based analyses of diffusion tensor MR imaging data

21 January 2018

1 reference

Dopamine-dependent frontostriatal planning deficits in early Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.26312

1 reference

2 September 2017

1 reference